Pharmacokinetic modeling and simulation of subcutaneous and intravenous IgG dosing in patients with primary immunodeficiency diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic modeling and simulation of subcutaneous and intravenous IgG dosing in patients with primary immunodeficiency diseases

Published:2022-03 Issue: Volume:104 Page:108472
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Navarro-Mora Graciela,Alberti Joan J.,Mondou Elsa,Vilardell David,Vicente Torres Juan,Ayguasanosa Jaume,Páez Antonio

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference40 articles.

1. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification;Bousfiha;J. Clin. Immunol.,2020

2. H. Chapel, J. Prevot, H.B. Gaspar, T. Español, F.A. Bonilla, L. Solis, J. Drabwell, and The Editorial Board for Working Party on Principles of Care at IPOPI, Primary Immune Deficiencies – Principles of Care, Front. Immunol. 5(627) (2014).

3. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases;Ochs;J. Clin. Immunol.,2006

4. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease;Jolles;Clin. Exp. Immunol.,2015

5. Update on the use of immunoglobulin in human disease: A review of evidence;Perez;J. Allergy Clin. Immunol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protecting children and adults with primary antibody deficiencies against common and emergent pathogens and non-infectious complications;Clinical and Experimental Immunology;2024-07-16

2. Recombinant streptococcal protein G-modified metal-organic framework ZIF-8 for the highly selective purification of immunoglobulin G from human serum;Analytica Chimica Acta;2024-02

3. Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies;Clinical and Experimental Immunology;2022-10-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3